12 Oct '21
Singapore Health Sciences Authority issues approval by its Pandemic Special Access Route (PSAR) for the LUCIRA CHECK IT COVID-19 Test Kit. Lucira has partnered with Labgistics Asia Pte Ltd for the importation and distribution of its products in Singapore. EMERYVILLE, Calif., Oct.
08 Oct '21
EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today commented on the recent recall
20 Sep '21
Veteran operations expert joins Lucira’s management team EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious
12 Aug '21
EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported
29 Jul '21
EMERYVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report second
28 May '21
Appointment expands Lucira’s management team with medtech veteran EMERYVILLE, Calif. --(BUSINESS WIRE)--May 28, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits,
13 May '21
EMERYVILLE, Calif, May 13, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported financial
12 May '21
This FDA EUA first and only PCR quality, single-use, COVID-19 at home, self-test kit is available for $55 to all Amazon US customers EMERYVILLE, Calif. --(BUSINESS WIRE)--May 12, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization
Displaying 1 - 10 of 20